📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Biofourmis

1.1 - Company Overview

Biofourmis Logo

Biofourmis

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of digital therapeutics and healthcare technology platforms for at-home patient monitoring, enabling personalized care and clinically validated software-based therapies. Offers remote patient management, Hospital at Home, transitional care, timely discharge, SNF at Home, and digital clinical trials with AI-enabled analytics, virtual visits, and remote data capture.

Products and services

  • Hospital at Home: A scalable system that uses continuous and episodic monitoring, AI-enabled analytics, and coordinated in-home services to deliver care for clinically-appropriate acute patients at home
  • Remote Patient Management: A clinically validated virtual care platform with personalized care plans, remote patient management, and patient engagement tools to help prevent post-discharge decompensation and reduce re-hospitalizations
  • Digital Clinical Trials: A software-based framework enabling life science companies to conduct trials anywhere using eConsent, ePRO, remote data capture, and virtual visits for complete remote participation

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Biofourmis

Axial Exchange Logo

Axial Exchange

HQ: United States Website
  • Description: Provider of a remote patient and population health monitoring and communications platform that detects complications between provider encounters and delivers real-time, trending health and behavior data to care teams. Solutions include automated care coordination, patient engagement mobile app, case management dashboard, data integration, transitional care management, and chronic care management services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Axial Exchange company profile →
AlayaCare Logo

AlayaCare

HQ: Canada Website
  • Description: Provider of an end-to-end home health care software platform and hardware ecosystem for agencies, enabling mixed telehealth and in-home care. Solutions span home care, home health, hospice and palliative, and infusion/specialty pharmacy, covering scheduling, documentation, medication management, agency operations, real-time patient information, mobile tools for caregivers, integration with pharmacy management solutions, and billing across multiple payer sources.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AlayaCare company profile →
CareCloud Logo

CareCloud

HQ: United States Website
  • Description: Provider of cloud-based, technology-enabled software and services for US medical practices, including revenue cycle management, practice management, electronic health records, patient engagement, digital health, and telemedicine solutions to streamline workflows, optimize finances, and improve patient care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CareCloud company profile →
Ametros Logo

Ametros

HQ: United States Website
  • Description: Provider of post-settlement medical administration solutions, serving as a neutral party working with injured parties, insurers, employers, attorneys, and Medicare to create a positive settlement experience, helping individuals save money on ongoing medical expenses and save time navigating the complex healthcare system.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ametros company profile →
Alegeus Logo

Alegeus

HQ: United States Website
  • Description: Provider of consumer directed healthcare solutions, including platforms for Health Savings Accounts, Flexible Spending Accounts (with AI-powered decision support and self-service), Health Reimbursement Arrangements (flexible platform supporting complex employer plan designs), COBRA administration (designed for scalability, efficiency, and an intuitive user experience), supplemental benefits (tailored to engage and retain members), and commuter benefits. Market leader supporting 40% of CDH benefit accounts.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alegeus company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Biofourmis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Biofourmis

2.2 - Growth funds investing in similar companies to Biofourmis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Biofourmis

4.2 - Public trading comparable groups for Biofourmis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Biofourmis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Biofourmis

What does Biofourmis do?

Biofourmis is a provider of digital therapeutics and healthcare technology platforms for at-home patient monitoring, enabling personalized care and clinically validated software-based therapies. Offers remote patient management, Hospital at Home, transitional care, timely discharge, SNF at Home, and digital clinical trials with AI-enabled analytics, virtual visits, and remote data capture.

Who are Biofourmis's competitors?

Biofourmis's competitors and similar companies include Axial Exchange, AlayaCare, CareCloud, Ametros, and Alegeus.

Where is Biofourmis headquartered?

Biofourmis is headquartered in United States.

How many employees does Biofourmis have?

Biofourmis has 1,000 employees 🔒.

When was Biofourmis founded?

Biofourmis was founded in 2010 🔒.

What sector and industry vertical is Biofourmis in?

Biofourmis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Biofourmis

Who are the top strategic acquirers in Biofourmis's sector and industry

Top strategic M&A buyers and acquirers in Biofourmis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Biofourmis?

Top strategic M&A buyers groups and sectors for Biofourmis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Biofourmis's sector and industry vertical

Which are the top PE firms investing in Biofourmis's sector and industry vertical?

Top PE firms investing in Biofourmis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Biofourmis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Biofourmis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Biofourmis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Biofourmis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Biofourmis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Biofourmis?

The key public trading comparables and valuation benchmarks for Biofourmis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Biofourmis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Biofourmis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Biofourmis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Biofourmis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Biofourmis's' sector and industry vertical?

Access recent funding rounds and capital raises in Biofourmis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Biofourmis